Kirkland & Ellis has advised KKR. Latham & Watkins has advised Apollo. Paul, Weiss, Rifkind, Wharton & Garrison LLP has advised Keurig Dr Pepper. Global investment...
KKR and Apollo Announce $3 Billion Convertible Preferred Stock Investment in Keurig Dr Pepper
Viridian Therapeutics Royalty Financing Agreement with DRI Healthcare for up to $300 Million
Ropes & Gray has advised Viridian Therapeutics. Weil and Ballard Spahr have advised DRI Healthcare. Latham & Watkins has advised the lender, Hercules Capital, on the...
SMART Global Holdings’ $175 Million Convertible Notes
Latham & Watkins advised SMART Global Holdings Inc. SMART Global Holdings, Inc. closed a US$175 million in aggregate principal amount of convertible senior notes due 2030,...
Heron Therapeutics’ Capital Credit Facility Agreement With Hercules Capital
Latham & Watkins advises on Heron Therapeutics’ working capital credit facility. Heron Therapeutics, Inc. (Heron), a commercial-stage biotechnology company focused on improving the lives of patients...
MindMed’s Senior Secured Credit Facility With K2 HealthVentures LLC
Latham & Watkins advises MindMed in growth financing with K2 HealthVentures. Mind Medicine Inc. (MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat...
Air Transport Services Group’s Convertible Senior Notes Offering
Latham & Watkins Advises on Air Transport Services Group’s Convertible Senior Notes Offering. Air Transport Services Group, Inc. (NASDAQ: ATSG) has announced the pricing of its...
Outset Medical’s $300 Million Debt Facilities
Cooley LLP advised Outset, while Latham & Watkins LLP represented SLR Capital Partners in the transaction. Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering...
Kura Oncology’s $125 Million Financing Agreement
Latham & Watkins LLP represented Hercules Capital, Inc. in the transaction. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
Tricida’s $125 Million Debt Facility
Latham & Watkins LLP represented Hercules in the transaction. Tricida, Inc. (Nasdaq: TCDA) has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a...
Spectrum Pharmaceuticals’ $65 Million Debt Financing Agreement With SLR Capital Partners
Latham & Watkins represented Spectrum Pharmaceuticals in the deal. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into...
Alignment Healthcare’ $250 Million Debt Financing
Latham & Watkins represented Alignment Healthcare in the transaction. Alignment Healthcare, Inc.(Alignment Healthcare) (NASDAQ: ALHC), a leading tech-enabled MedicareAdvantage company, has announced the close of an...
Marti’s Merger with Galata Acquisition Corp.
Latham & Watkins and Conyers represented Marti Technologies Inc. in the transaction. Willkie Farr & Gallagher represented Galata. White & Case represented B. Riley Securities. Galata Acquisition...